Brexit: UK Gov’t Warns Against Medicines Stockpiling By NHS And Public
The UK government has issued guidance on actions the public health and care system in England should take to prepare for and cope with a potential “no deal” exit by the UK from the EU at the end of March next year. The government is also very clear on what it does not want providers such as hospitals and community pharmacies to do – stockpile medicines.
You may also be interested in...
With the UK no nearer to deciding how hard or soft its exit from the EU will be on March 29, AstraZeneca and Ipsen have given updates on their efforts to cope with the chaos that could ensue on the medicines supply front.
EU marketing applications from Vertex and Roche have reverted to standard review timelines at the European Medicines Agency. The outcomes of three fast-track requests that companies have made for their planned filings are still unknown.